Fig. 1From: Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life studyNumber of patients included in the study grouped by intravitreal treatment drug. The number of patients for whom one to five years of follow-up data is available is displayedBack to article page